Alfresa HoldingsAlfresa Holdings Corporation2784東証プライム卸売業FY ending Mar 2026, consolidated, J-GAAP
Revenue by business segment, and the profit each one keeps.
Geographic revenue reported in annual filings
No geographic revenue breakdown was disclosed.
※ Segment figures include inter-segment sales and do not sum to the company total
X-axis: segment revenue CAGR. Y-axis: latest operating margin. Bubble size: revenue.
Bubble size represents latest revenue. Segments without a CAGR are placed at the left edge; their horizontal position is not a growth value. Color indicates positive or negative margin.
| Segment | Revenue CAGR | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|---|
| Ethical Pharmaceuticals Wholesaling business | +3.9%5y | 2,272,3571.1% | 2,378,5311.1% | 2,521,9061.3% | 2,621,0621.3% | 2,763,0821.2% |
| Self-medication Products Wholesaling business | +0.4%5y | 244,2120.8% | 246,1520.9% | 262,3441.0% | 265,2751.1% | 266,6261.1% |
| Manufacturing business | +2.3%5y | 34,6055.4% | 35,1831.2% | 37,5945.0% | 37,6903.4% | 37,1813.2% |
| Medical-Related Business | — | 34,4680.5% | 36,2020.9% | 36,6541.9% | 37,0231.6% | — |
| Dispensing Pharmacy and Related businesses | N/A | — | — | — | 37,0231.6% | 37,1741.3% |
Top: revenue. Bottom: operating margin.
EDINET (FSA Japan)
有価証券報告書-第23期(2025/04/01-2026/03/31)
EDINET (FSA Japan)
有価証券報告書-第22期(2024/04/01-2025/03/31)
EDINET (FSA Japan)
有価証券報告書-第21期(2023/04/01-2024/03/31)
EDINET (FSA Japan)
有価証券報告書-第20期(2022/04/01-2023/03/31)
EDINET (FSA Japan)
有価証券報告書-第19期(令和3年4月1日-令和4年3月31日)
EDINET (FSA Japan)
有価証券報告書-第18期(令和2年4月1日-令和3年3月31日)
Extracted from XBRL: 54 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.